(Tony Sifert, Headline USA) Now that the novelty of the war between Russia and the Ukraine is wearing off, the biomedical security state is again looking to stoke COVID-19 anxiety in time for the 2022 midterms — young and old alike beware!
The Biden administration is mulling an authorization of a second booster shot for Americans over the age of 65 “as a result of the spread of the Omicron subvariant, BA.2,” according to Politico.
A second booster shot would require a new set of negotiations between the government and Big Pharma.
“The government needs to begin negotiating new supply deals with Pfizer and Moderna at the beginning of April to ensure doses are delivered by the fall . . . a process that cannot begin until Congress passes more funding,” one official told Politico.
Moderna is also taking the opportunity to push its questionably needed and largely ineffective “low-dose” vaccines for children between the ages of 6 months and 6 years, reported the AP.
The pharmaceutical company issued a press release Wednesday announcing “positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine (mRNA-1273) in children 6 months to under 2 years and 2 years to under 6 years of age.”
“We now have clinical data on the performance of our vaccine from infants six months of age through older adults,” Stéphane Bancel, Chief Executive Officer of Moderna, said.
“Given the need for a vaccine against COVID-19 in infants and young children,” Bancel said, “we are working with the U.S. FDA and regulators globally to submit these data as soon as possible.”
“The announcement is positive news for parents who have anxiously awaited protection for younger tots and been continuously disappointed by setbacks and confusion over which shots might work and when,” gushed the AP. “The nation’s 18 million children under 5 are the only age group not yet eligible for vaccination.”
At Hot Air, Ed Morrissey offers a clue as to why.
“The CDC’s data — which still includes correlative deaths and hospital admissions rather than only causative — shows children below the age of six as having nearly no risk of death at all from COVID-19,” Morrissey wrote.
“With that in mind, the pursuit of a vaccine for these age groups seems like a waste of time and resources,” he concluded.
